Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Facile Method for the Investigation of Temperature-Dependent C60 Diffusion in Conjugated Polymers.

Saller C, Kahle FJ, Müller T, Hahn T, Tscheuschner S, Priadko D, Strohriegl P, Bässler H, Köhler A.

ACS Appl Mater Interfaces. 2018 Jun 27;10(25):21499-21509. doi: 10.1021/acsami.8b05520. Epub 2018 Jun 14.

PMID:
29847088
2.

MAP2 IHC detection: a marker of antigenicity in CNS tissues.

D'Andrea MR, Howanski RJ, Saller CF.

Biotech Histochem. 2017;92(5):363-373. doi: 10.1080/10520295.2017.1295169. Epub 2017 Aug 2.

PMID:
28766965
3.

Seroquel: biochemical profile of a potential atypical antipsychotic.

Saller CF, Salama AI.

Psychopharmacology (Berl). 1993;112(2-3):285-92.

PMID:
7871032
4.

Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat.

Mercugliano M, Saller CF, Salama AI, U'Prichard DC, Chesselet MF.

Neuropsychopharmacology. 1992 May;6(3):179-87.

PMID:
1599608
5.

Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes.

Saller CF, Kreamer LD.

Brain Res. 1991 Apr 19;546(2):235-40.

PMID:
1829974
6.

5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade.

Saller CF, Czupryna MJ, Salama AI.

J Pharmacol Exp Ther. 1990 Jun;253(3):1162-70.

PMID:
2141636
7.

Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat.

Fuxe K, von Euler G, Agnati LF, Saller CF, Salama A, Goldstein M.

Neurosci Lett. 1989 Nov 20;106(1-2):169-74.

PMID:
2531306
9.

Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

Saller CF, Kreamer LD, Adamovage LA, Salama AI.

Life Sci. 1989;45(10):917-29.

PMID:
2529407
10.

3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.

Saller CF, Salama AI.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):125-32.

PMID:
2878374
11.

D-1 dopamine receptor stimulation elevates plasma prolactin levels.

Saller CF, Salama AI.

Eur J Pharmacol. 1986 Mar 11;122(1):139-42.

PMID:
3007174
12.

D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.

Saller CF, Salama AI.

J Pharmacol Exp Ther. 1986 Mar;236(3):714-20.

PMID:
3005552
13.

Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.

Saller CF, Salama AI.

Eur J Pharmacol. 1986 Feb 18;121(2):181-8.

PMID:
3699091
14.

Functional interactive effects of D1 and D2 dopamine receptor blockade.

Salama AI, Saller CF.

Adv Exp Med Biol. 1986;204:137-50. No abstract available.

PMID:
2947425
15.

Homocysteine prevents apomorphine-induced decreases in dopamine metabolites.

Saller CF, Salama AI.

Brain Res. 1985 Dec 23;360(1-2):407-8.

PMID:
4075182
16.

Modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia.

Lozovsky DB, Kopin IJ, Saller CF.

Brain Res. 1985 Sep 16;343(1):190-3.

PMID:
3899277
17.
18.

Inhibition of protein carboxylmethylation and dopamine autoreceptor functioning.

Saller CF, Salama AI.

Eur J Pharmacol. 1985 Apr 23;111(1):17-22.

PMID:
4018124
19.

Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.

Saller CF, Salama AI.

Eur J Pharmacol. 1985 Feb 26;109(2):297-300.

PMID:
3873343
22.

Dopaminergic activity is reduced in diabetic rats.

Saller CF.

Neurosci Lett. 1984 Aug 31;49(3):301-6.

PMID:
6493613
24.

Effects of phencyclidine on rat prolactin, dopamine receptor and locomotor activity.

Lozovsky D, Saller CF, Bayorh MA, Chiueh CC, Rice KC, Burke TR Jr, Kopin IJ.

Life Sci. 1983 Jun 13;32(24):2725-31.

PMID:
6855468
25.

Lithium and the prevention of dopamine receptor supersensitivity in diabetic rats.

Lozovsky D, Saller CF, Kopin IJ.

Am J Psychiatry. 1983 May;140(5):613-4.

PMID:
6303136
26.

Phencyclidine suppresses plasma prolactin levels.

Saller CF, Zerbe RL, Bayorh MA, Lozovsky D, Kopin IJ.

Eur J Pharmacol. 1982 Sep 24;83(3-4):309-11. No abstract available.

PMID:
7173312
27.

Glucose potentiates haloperidol-induced catalepsy.

Saller CF, Kopin IJ.

Life Sci. 1981 Nov 30;29(22):2337-41. No abstract available.

PMID:
7198706
28.

Dopamine receptor binding is increased in diabetic rats.

Lozovsky D, Saller CF, Kopin IJ.

Science. 1981 Nov 27;214(4524):1031-3.

PMID:
6458088
29.

Estrogen potentiates the stereotypy induced by dopamine agonists in the rat.

Chiodo LA, Caggiula AR, Saller CF.

Life Sci. 1981 Feb 16;28(7):827-35. No abstract available.

PMID:
7194960
30.
31.

Estrogen increases both spiperone-induced catalepsy and brain levels of [3H]spiperone in the rat.

Chiodo LA, Caggiula AR, Saller CF.

Brain Res. 1979 Aug 24;172(2):360-6. No abstract available.

PMID:
572736
32.

Decreased gastrointestinal motility in rats after parenteral injection of p-chlorophenylalanine.

Saller CF, Stricker EM.

J Pharm Pharmacol. 1978 Oct;30(10):646-7. No abstract available.

PMID:
30821
33.

A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid.

Saller CF, Zigmond MJ.

Life Sci. 1978 Sep 18;23(11):1117-30. No abstract available.

PMID:
30872
34.

Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.

Saller CF, Stricker EM.

Neuropharmacology. 1978 Jul;17(7):499-506. No abstract available.

PMID:
692815
35.

Homeostasis during hypoglycemia: central control of adrenal secretion and peripheral control of feeding.

Stricker EM, Rowland N, Saller CF, Friedman MI.

Science. 1977 Apr 1;196(4285):79-81.

PMID:
841345
36.
37.

Inhibition of normal growth by chronic administration of delta-9-tetrahydrocannabinol.

Manning FJ, McDonough JH Jr, Elsmore TF, Saller C, Sodetz FJ.

Science. 1971 Oct 22;174(4007):424-6.

PMID:
5111999

Supplemental Content

Loading ...
Support Center